Engineering - Pharma Rep Focus

Nym Rakes In $47M for Autonomous Coding Engine

MedCity News

OCTOBER 1, 2024

The post Nym Rakes In $47M for Autonomous Coding Engine appeared first on MedCity News. Autonomous coding startup Nym raised $47 million. The New York City-based company has 21 provider customers, including Geisinger and Ochsner Health.

Engineering

Engineering Medical Pharma

Re-engineering Cancer Clinical Trials at Scale

MedCity News

DECEMBER 22, 2022

Engineers see everything as a system, know how to design under constraints, and recognize the need for trade-offs. Adopting an engineering mindset in oncology research can fix all the broken constituent processes like patient enrollment to systematize clinical trials.

Engineering

Engineering Patients Biopharma

Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products

MedCity News

AUGUST 2, 2024

The post Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products appeared first on MedCity News. While the approach to patient and treatment safety is crucial, there is a notable shift towards processes centered around patients and healthcare professionals.

Engineering

Engineering Medical Safety Healthcare

Webinars

The Intersection of AI and Sales: Personalization Without Compromise

MORE WEBINARS

FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

Fierce Pharma

AUGUST 2, 2024

Adaptimmune has won accelerated FDA approval | Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma which becomes the first engineered cell therapy for a solid tumor and the first new treatment in the indication in more than a decade.

Engineering

Engineering FDA

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

What You’ll Learn: 🌐 State of AI Today: Discover how AI powers tools you already use, from search engines to recommendation systems. Whether you’re just starting your AI journey or looking to refine your approach, this session will give you the tools to thrive in the AI-driven future.

Sales

Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors

MedCity News

AUGUST 2, 2024

It’s the first engineered cell therapy approved for treating a solid tumor. The post Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors appeared first on MedCity News. The FDA approved Adaptimmune Therapeutics’ Tecelra as a treatment for advanced cases of synovial sarcoma.

Engineering

Engineering FDA Biopharma Pharma

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

MedCity News

NOVEMBER 10, 2024

While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia.

FDA

FDA Engineering Safety Biopharma

Novome gets $43.5M boost for its engineered microbiome therapies

MedCity News

SEPTEMBER 13, 2022

Novome Biotechnologies — a biotech that CEO Blake Wise says is only company to pursue engineered cell therapy with microbes for the treatment of chronic diseases — raised $43.5 million in Series B funds.

Engineering

Engineering Leads Patients Biopharma

3 Ways to Use an Engineering Mindset to Optimize Patient Access Workflows

MedCity News

SEPTEMBER 6, 2023

In a day of vast innovation, expansion, and acquisitions, an engineering mindset can bring a unique and effective approach to thinking across the system, evaluating the current and future state, standardizing on best practices, and considering upstream and downstream workflows.

Engineering

Engineering Patients

The 5 Stages of Account-Based Marketing — and How to Win Them All

Advertiser: ZoomInfo

Data is the fuel that powers your ABM engine. The benefits of account-based marketing are clear: internal alignment, shorter sales cycles, higher conversion rates. But none of this is possible without the most important element of a successful ABM program: good data. Without it, you can’t find and reach your target accounts.

Marketing

Penn spinout Capstan aims for next cell therapy frontier: in vivo cell engineering

MedCity News

SEPTEMBER 14, 2022

Capstan Therapeutics, a University of Pennsylvania spinout, is now out of stealth with technology that could enable new medicines that work by engineering cells inside of a patient.

Engineering

Engineering Medicine Patients Biopharma

Fine-Tuning, Prompt Engineering are Keys to Delivering Real Generative AI Solutions to Commercial Pharma Operations Today

MedCity News

AUGUST 15, 2023

Generative AI further enhances the value of prompt engineering by synthesizing important insights from various interactions, including text, images, compliant transcripts, and call notes. By automating this process, generative AI quickly transforms on-the-ground insights into robust analytics.

Engineering

Engineering Pharma Manufacturing Biopharma

After wild pandemic ride, is Novavax destined to be the little engine that couldn’t?

Fierce Pharma

MARCH 1, 2023

After wild pandemic ride, is Novavax destined to be the little engine that couldn’t? kdunleavy Wed, 03/01/2023 - 07:10

Engineering

Twentyeight Health Raises $10M, Secures New Medicaid Partnerships

MedCity News

JANUARY 9, 2025

Twentyeight Health’s $10 million Series A round was led by Seae Ventures and included participation from Impact America Fund, The Social Entrepreneurs’ Fund, RH Capital, Impact Engine, Gratitude Railroad and Townhall Ventures.

Engineering

How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout?

MedCity News

MARCH 7, 2025

[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar with Elation Health executives Dr Sara Pastoor, head of primary care advancement, and Meaghan Sullivan, senior sales engineer. The post How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout? appeared first on MedCity News.

Engineering

Engineering Sales Physicians

How Big Pharma keeps the oncology engines hot with a host of strategies

PharmaVoice

NOVEMBER 2, 2023

From Merck and J&J to AbbVie and Eisai, the oncology field has stayed consistently devoted to churning out important therapies.

Engineering

Engineering Pharma

Babylon Health’s CEO ‘Should Spend Some Time With Elizabeth Holmes’

MedCity News

SEPTEMBER 12, 2023

After Babylon collapsed, a former employee also publicly declared that the AI engine was faulty. doctor David Watkins has been a public critic of Babylon Health for years, during which has received anonymous emails from Babylon employees saying that the company’s AI is a sham.

Engineering

Engineering Doctors Healthcare Healthcare

Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024

MedCity News

JANUARY 25, 2024

The clinical program spans tests of the engineered virus as a monotherapy and as part of combination treatments. CG Oncology’s upsized IPO will support pivotal testing of cretostimogene, an oncolytic virus for non-muscle invasive bladder cancer.

Engineering

Engineering Biopharma Pharma

J&J Adds Another Bispecific Antibody for Atopic Dermatitis With $1.25B Acquisition

MedCity News

MAY 28, 2024

Johnson & Johnson is acquiring a bispecific antibody that Numab Therapeutics engineered to address two pathways associated with the inflammation and itching of atopic dermatitis. It’s J&J’s second immunology acquisition this month.

Engineering

Engineering Biopharma Pharma

DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video)

MedCity News

JANUARY 27, 2025

genAI engine on a simple healthcare industry question? The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. The post DeepSeek v. ChatGPT: Why is healthcare so expensive in America? Video) appeared first on MedCity News.

Healthcare

Healthcare Healthcare Engineering

Cargo Therapeutics’ IPO Loads Up $281M for a Cancer Cell Therapy’s Pivotal Study

MedCity News

NOVEMBER 10, 2023

Cargo Therapeutics will use most of the IPO proceeds for clinical testing of a cell therapy engineered to overcome a common way cancers develop resistance. This program is based on research from the National Cancer Institute.

Engineering

Engineering Biopharma Pharma

This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics

MedCity News

MAY 10, 2024

By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing. The company, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field.

Manufacturing

Manufacturing Engineering Biopharma

Aiming to Top Amgen in Gout, Startup GRObio Gets $60M to Enter the Clinic

MedCity News

JULY 19, 2024

Harvard spinout GRO Biosciences has a platform technology for engineering therapeutic proteins that won’t prompt an immune response against them. The startup’s lead program is a potential competitor to an Amgen gout drug acquired in a multi-billion dollar deal.

Engineering

Engineering Leads Biopharma

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI [Sponsored]

MedCity News

OCTOBER 25, 2023

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.

Engineering

Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’

MedCity News

OCTOBER 24, 2024

Radiant Biotherapeutics’ Multabodies are antibodies engineered to offer better binding strength to their targets. The preclinical startup’s lead program goes after a cancer immunotherapy target being pursued by several biotech companies already in early clinical development.

Engineering

Engineering Leads Biopharma Pharma

Chiesi Wins FDA Approval for First Drug to Treat Ultra-Rare Enzyme Deficiency

MedCity News

FEBRUARY 17, 2023

Chiesi drug Lamzede is an engineered version of an enzyme that’s lacking in patients with the rare disease alpha-mannosidosis. FDA approval of the Chiesi drug comes about five years after European regulators authorized the product.

FDA

FDA Engineering Patients Biopharma

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

OCTOBER 31, 2023

In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients. I am a field clinical engineer. People come from sales, clinical, and engineers. Nursing to engineering.

Engineering

Engineering Sales Medical sales Medical

With New Kind of CAR, Cancer Startup Cargo Refuels With $200M for Cell Therapy Race

MedCity News

MARCH 3, 2023

True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells. Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments.

Engineering

Engineering Biopharma Pharma

Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery

MedCity News

OCTOBER 21, 2022

Surge Therapeutics’ hydrogel is engineered to deliver a cancer immunotherapy. Rather than replace surgery, CEO Michael Goldberg says the hydrogel could supplement this standard of care for solid tumors. The startup’s Series A financing will support the technology’s first test in humans.

Engineering

Engineering Biopharma Pharma

Re-engineering proteins to develop novel immunotherapies

European Pharmaceutical Review

JULY 13, 2023

By re-engineering existing approaches that have already shown clinical promise, there is potential to bring further benefit to the patient community in its fight against cancer. Since then, several next-generation antibodies have been engineered with modifications that enable them to better engage with immune cells.

Engineering

Engineering Food and Drug Administration Patients Safety

With MS & Fibrosis Trials Planned, J&J-Partnered Contineum Now Preps for IPO

MedCity News

MARCH 18, 2024

Contineum Therapeutics, which emerged from a Verant Ventures startup creation engine, has filed paperwork for an IPO. The biotech’s clinical-stage pipeline spans multiple sclerosis, idiopathic pulmonary fibrosis, and depression.

Engineering

Engineering Biopharma Pharma

FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy

MedCity News

JUNE 22, 2023

Elevidys is an engineered version of a gene intended to restore function lost to the mutation at the root of the inherited muscle disease. Sarepta Therapeutics’ Elevidys is now the first FDA-approved gene therapy for Duchenne muscular dystrophy.

FDA

FDA Engineering Biopharma Pharma

Already Partnered With Nvidia and Eli Lilly, Iambic Adds $100M for AI Drug Discovery

MedCity News

OCTOBER 4, 2023

Iambic Therapeutics brings together software engineers and drug-hunting scientists, all sharing the goal of using artificial intelligence to optimize properties of small molecule drugs. The startup will apply its Series B financing to a cancer drug pipeline that includes two candidates on track for the clinic in 2024.

Engineering

Engineering Biopharma

FDA approves innovative engineered cell therapy

European Pharmaceutical Review

AUGUST 2, 2024

The post FDA approves innovative engineered cell therapy appeared first on European Pharmaceutical Review. With US approval TECELRA, “there is a renewed sense of hope for this patient community.”

Engineering

Engineering FDA Food and Drug Administration Food

NYU Langone advances cardiac xenotransplant research to address organ shortage for transplants

MedCity News

JULY 12, 2022

In the past 30 days, the health system successfully transplanted two genetically engineered pig hearts into deceased humans who donated their bodies to medical research. NYU Langone is advancing xenotransplant research to address the organ shortage for transplants.

Engineering

Engineering Medical

Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

PharmaVoice

SEPTEMBER 15, 2022

Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

Engineering

Engineering Specialization

Demystifying FHIR APIs

MedCity News

OCTOBER 6, 2022

In migrating from HL7 v2 (or a proprietary format) to FHIR, your IT or engineering group will be teaching a dozen different systems to speak a new, highly technical language.

Engineering

FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection

MedCity News

JULY 17, 2023

Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season. AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers.

FDA

FDA Engineering Biopharma Pharma

Novartis warns of two patients deaths after dosing with gene therapy Zolgensma

MedCity News

AUGUST 12, 2022

Liver complications are a known side effect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.

Side effects

Side effects Engineering Patients Medicine

From Bottlenecks to Breakthroughs: Using Technology to Transform Specialty Medication Access and Affordability

MedCity News

AUGUST 1, 2023

We need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior authorization, from real-time benefit checks to financial assistance — on a central platform powered by a business rules engine, automated workflows, and real-time analytics.

Engineering

Engineering Medical Patients Biopharma

Stanford spinout 3T Bio snags $40M for immunotherapies targeted to solid tumors

MedCity News

AUGUST 25, 2022

Artificial intelligence and machine learning are key to 3T Biosciences’ approach to identifying novel drug targets and engineering better, safer cancer immunotherapies. The Stanford spinout is now out of stealth with a $40 million Series A financing and a plan to reach the clinic within two years.

Engineering

Engineering Biopharma Pharma

Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna

Pharmaceutical Technology

APRIL 30, 2024

Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research. Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells.

Engineering

Nanoparticle drug delivery innovation could enhance drug development

European Pharmaceutical Review

DECEMBER 23, 2024

can be engineered by selecting different biomolecules, metal ions and assembly conditions [providing] a modular approach to construct multifunctional nanoparticles with diverse compositions, stated Professor Frank Caruso, Department of Chemical Engineering, University of Melbourne, Australia.

Engineering

Engineering Networking Safety Pharmaceutical

Enabling Science at Scale

Fierce Pharma

JUNE 13, 2023

By: William Blake, Chief Technology Officer, Human-Based R&D | Danaher Life Sciences companies are ushering in a new era of engineering biology, partnering with biopharma leaders to deploy automation, AI and other engineering practices from early research through manufacturing.

Engineering

Engineering Biopharma Manufacturing

Nym Rakes In $47M for Autonomous Coding Engine

Re-engineering Cancer Clinical Trials at Scale

Webinars

Trending Sources

Beyond Engineering: Integrating UX for Safer and More Efficient Medical Products

Webinars

FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

Novome gets $43.5M boost for its engineered microbiome therapies

3 Ways to Use an Engineering Mindset to Optimize Patient Access Workflows

The 5 Stages of Account-Based Marketing — and How to Win Them All

Penn spinout Capstan aims for next cell therapy frontier: in vivo cell engineering

Fine-Tuning, Prompt Engineering are Keys to Delivering Real Generative AI Solutions to Commercial Pharma Operations Today

After wild pandemic ride, is Novavax destined to be the little engine that couldn’t?

Twentyeight Health Raises $10M, Secures New Medicaid Partnerships

How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout?

How Big Pharma keeps the oncology engines hot with a host of strategies

Babylon Health’s CEO ‘Should Spend Some Time With Elizabeth Holmes’

Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024

J&J Adds Another Bispecific Antibody for Atopic Dermatitis With $1.25B Acquisition

DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video)

Cargo Therapeutics’ IPO Loads Up $281M for a Cancer Cell Therapy’s Pivotal Study

This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics

Aiming to Top Amgen in Gout, Startup GRObio Gets $60M to Enter the Clinic

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI [Sponsored]

Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’

Chiesi Wins FDA Approval for First Drug to Treat Ultra-Rare Enzyme Deficiency

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

With New Kind of CAR, Cancer Startup Cargo Refuels With $200M for Cell Therapy Race

Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery

Re-engineering proteins to develop novel immunotherapies

With MS & Fibrosis Trials Planned, J&J-Partnered Contineum Now Preps for IPO

FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy

Already Partnered With Nvidia and Eli Lilly, Iambic Adds $100M for AI Drug Discovery

FDA approves innovative engineered cell therapy

NYU Langone advances cardiac xenotransplant research to address organ shortage for transplants

Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

Demystifying FHIR APIs

FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection

Novartis warns of two patients deaths after dosing with gene therapy Zolgensma

From Bottlenecks to Breakthroughs: Using Technology to Transform Specialty Medication Access and Affordability

Stanford spinout 3T Bio snags $40M for immunotherapies targeted to solid tumors

Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna

Nanoparticle drug delivery innovation could enhance drug development

Enabling Science at Scale

Stay Connected